Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism

The purpose of this study was to assess the clinical usefulness of assaying the fibroblast growth factor (FGF-23), Klotho, osteocalcin, N-terminal telopeptide of type I collagen (NTX), and sclerostin levels in patients with primary hyperparathyroidism (PHPT) as markers of bone damage as well as for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sykała, Monika, Szumowski, Piotr, Mojsak, Małgorzata, Abdelrazek, Saeid, Żukowski, Łukasz, Lipińska, Danuta, Juchnicka, Ilona, Kozłowska, Gabryela, Szelachowska, Małgorzata, Krętowski, Adam, Myśliwiec, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303928/
https://www.ncbi.nlm.nih.gov/pubmed/34300255
http://dx.doi.org/10.3390/jcm10143089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303928/
https://www.ncbi.nlm.nih.gov/pubmed/34300255
http://dx.doi.org/10.3390/jcm10143089

Ejemplares similares